StockData
BIO-TECHNE Corp logo

BIO-TECHNE Corp (TECH) stock

TECHNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 11/3040% above fair value
$72.80−0.02 (-0.03%)

Close on Nov 11, 2026Market cap $11.43BP/E 66.8Yield 0.44%

Bio-Techne gross margin

Gross margin is gross profit as a percentage of revenue.

Bio-Techne's gross margin for the twelve months ending Sep 30, 2026 was 65.8%. For fiscal 2026 it was 65.8%, against 64.8% the year before. The highest annual figure on record is 79.6% in fiscal 2010.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2026Jun 30, 202665.8%+1.0
FY2025Jun 30, 202564.8%−1.6
FY2024Jun 30, 202466.4%−1.3
FY2023Jun 30, 202367.7%−0.7
FY2022Jun 30, 202268.4%+0.5
FY2021Jun 30, 202168.0%+2.6
FY2020Jun 30, 202065.4%−0.9
FY2019Jun 30, 201966.3%−0.9
FY2018Jun 30, 201867.2%+0.7
FY2017Jun 30, 201766.5%−0.9
FY2016Jun 30, 201667.5%−0.5
FY2015Jun 30, 201567.9%−2.3
FY2014Jun 30, 201470.3%−4.1
FY2013Jun 30, 201374.4%−0.5
FY2012Jun 30, 201275.0%−2.6
FY2011Jun 30, 201177.6%−2.0
FY2010Jun 30, 201079.6%+0.8
FY2009Jun 30, 200978.8%–

Quarterly gross margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q1 FY2027CQ3 2026Sep 30, 202665.6%−0.0
Q4 FY2026CQ2 2026Jun 30, 202665.8%+3.1
Q3 FY2026CQ1 2026Mar 31, 202666.9%−1.0
Q2 FY2026CQ4 2025Dec 31, 202564.6%−0.6
Q1 FY2026CQ3 2025Sep 30, 202565.6%+2.4
Q4 FY2025CQ2 2025Jun 30, 202562.7%−3.7
Q3 FY2025CQ1 2025Mar 31, 202567.9%+0.4
Q2 FY2025CQ4 2024Dec 31, 202465.3%+0.5
Q1 FY2025CQ3 2024Sep 30, 202463.2%−3.6
Q4 FY2024CQ2 2024Jun 30, 202466.4%−1.5
Q3 FY2024CQ1 2024Mar 31, 202467.4%−1.3
Q2 FY2024CQ4 2023Dec 31, 202364.8%−2.7
Q1 FY2024CQ3 2023Sep 30, 202366.9%+0.3
Q4 FY2023CQ2 2023Jun 30, 202367.9%−1.6
Q3 FY2023CQ1 2023Mar 31, 202368.7%−0.6
Q2 FY2023CQ4 2022Dec 31, 202267.5%−0.7
Q1 FY2023CQ3 2022Sep 30, 202266.6%+0.3
Q4 FY2022CQ2 2022Jun 30, 202269.5%+1.6
Q3 FY2022CQ1 2022Mar 31, 202269.4%+0.3
Q2 FY2022CQ4 2021Dec 31, 202168.2%+0.9
Q1 FY2022CQ3 2021Sep 30, 202166.4%−1.1
Q4 FY2021CQ2 2021Jun 30, 202167.9%+3.5
Q3 FY2021CQ1 2021Mar 31, 202169.1%+2.3
Q2 FY2021CQ4 2020Dec 31, 202067.3%+1.6
Q1 FY2021CQ3 2020Sep 30, 202067.4%+2.8
Q4 FY2020CQ2 2020Jun 30, 202064.4%−2.5
Q3 FY2020CQ1 2020Mar 31, 202066.8%−0.6
Q2 FY2020CQ4 2019Dec 31, 201965.6%+0.9
Q1 FY2020CQ3 2019Sep 30, 201964.6%−1.4
Q4 FY2019CQ2 2019Jun 30, 201966.9%−0.9
Q3 FY2019CQ1 2019Mar 31, 201967.4%+0.2
Q2 FY2019CQ4 2018Dec 31, 201864.8%−1.3
Q1 FY2019CQ3 2018Sep 30, 201866.0%−1.6
Q4 FY2018CQ2 2018Jun 30, 201867.8%+2.4
Q3 FY2018CQ1 2018Mar 31, 201867.2%+0.1
Q2 FY2018CQ4 2017Dec 31, 201766.1%−0.8
Q1 FY2018CQ3 2017Sep 30, 201767.7%–
Q4 FY2017CQ2 2017Jun 30, 201765.4%–
Q3 FY2017CQ1 2017Mar 31, 201767.1%–
Q2 FY2017CQ4 2016Dec 31, 201666.9%–

More Bio-Techne figures

See a number that looks wrong?